Aylin Reyhani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Aylin Reyhani has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Murat Mert Atmaca
Clinic of Neurology, University of Health Sciences Türkiye, Sultan II. Abdulhamid Han Training and Research Hospital, İstanbul, Türkiye
2 shared publications - Selda Keskin Guler
University of Health Sciences, Ankara Training and Research Hospital, Department of Neurology, Ankara, Turkey
2 shared publications - Sibel Üstün Özek
Univ Hlth Sci Turkey, Prof Dr Cemil Tascioglu City Hosp, Clin Neurol, Istanbul, Turkey
2 shared publications - Vasfiye Kabeloglu
Department of Neurology, Health Sciences University, Bakirkoy Prof. Dr. Mazhar Osman Mental Health and Neurological Diseases Training and Research Hospital, Istanbul, Turkey
2 shared publications - Abdurrahman Neyal
Dr. Ersin Arslan Training and Research Hospital, Gaziantep, Turkey
1 shared publication - Ahmet Küçük
University of Health Sciences, Konya Beyhekim Training and Research Hospital, Neurology Clinic, Konya, Türkiye
1 shared publication
Latest Publications
- 4 April 2025
- Published by Elsevier in Epilepsy Research
- Vol. 213, 107551
Enteral topiramate treatment in refractory status epilepticus
- 4 April 2025
- Published by Elsevier in Epilepsy Research
- Vol. 213, 107551
Enteral topiramate treatment in refractory status epilepticus
- 22 December 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 150, 109568
The effect of sleep disorders on quality of life in patients with epilepsy: A multicenter study from Turkey
- 22 December 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 150, 109568
The effect of sleep disorders on quality of life in patients with epilepsy: A multicenter study from Turkey
- 11 August 2021
- Published by Galenos Yayinevi in Journal of Turkish Sleep Medicine
- Vol. 8 (3) , 197-202
Clinical and Polysomnographic Comparison of Patients with Rapid Eye Movementdependent and Positional Obstructive Sleep Apnoea Syndromes
- 11 August 2021
- Published by Galenos Yayinevi in Journal of Turkish Sleep Medicine
- Vol. 8 (3) , 197-202
Clinical and Polysomnographic Comparison of Patients with Rapid Eye Movementdependent and Positional Obstructive Sleep Apnoea Syndromes
- 26 May 2021
- Published by Galenos Yayinevi in Journal of Turkish Sleep Medicine
- Vol. 8 (2) , 136-141
Evaluation of Inflammation in Restless Legs Syndrome
- 26 May 2021
- Published by Galenos Yayinevi in Journal of Turkish Sleep Medicine
- Vol. 8 (2) , 136-141
Evaluation of Inflammation in Restless Legs Syndrome
- 1 May 2021
- Published by Elsevier in Epilepsy Research
- Vol. 172, 106575
The unchanging face of Lennox-Gastaut syndrome in adulthood
- 1 May 2021
- Published by Elsevier in Epilepsy Research
- Vol. 172, 106575
The unchanging face of Lennox-Gastaut syndrome in adulthood
- 30 December 2020
- Published by Eurasian Society of Family Medicine in Eurasian Journal of Family Medicine
- Vol. 9 (4) , 251-254
A Rare Etiology of Bilateral Foot Drop: Weight Loss
Excessive weight loss especially when it occurs in a short period of time can lead to some neurological problems including peroneal nerve palsy. Foot drop is the most common presentation of peroneal neuropathies and they rarely occur bilaterally at the same time. Herein, we presented a 46-year-old male patient who developed bilateral foot drop after losing 25 kgs. in two months with an intensive weight reduction diet which was advised by a doctor as a therapeutic regimen. The electromyographic study confirmed the bilateral entrapment neuropathy of the peroneal nerves at the fibular necks and these findings could not be attributed to any other factor except the weight loss. After a balanced diet and a physiotherapy programme, he recovered completely. This case highlights an uncommon but a well documented etiology of peroneal neuropathies. Being aware of this complication and close follow-up are important for the prognosis of these patients. Keywords: foot deformities, peroneal neuropathies, weight loss
- 30 December 2020
- Published by Eurasian Society of Family Medicine in Eurasian Journal of Family Medicine
- Vol. 9 (4) , 251-254
A Rare Etiology of Bilateral Foot Drop: Weight Loss
Excessive weight loss especially when it occurs in a short period of time can lead to some neurological problems including peroneal nerve palsy. Foot drop is the most common presentation of peroneal neuropathies and they rarely occur bilaterally at the same time. Herein, we presented a 46-year-old male patient who developed bilateral foot drop after losing 25 kgs. in two months with an intensive weight reduction diet which was advised by a doctor as a therapeutic regimen. The electromyographic study confirmed the bilateral entrapment neuropathy of the peroneal nerves at the fibular necks and these findings could not be attributed to any other factor except the weight loss. After a balanced diet and a physiotherapy programme, he recovered completely. This case highlights an uncommon but a well documented etiology of peroneal neuropathies. Being aware of this complication and close follow-up are important for the prognosis of these patients. Keywords: foot deformities, peroneal neuropathies, weight loss
- 28 April 2017
- Published by Springer Nature in Neurological Sciences
- Vol. 38 (7) , 1287-1291
High asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in migraine patients
Experimental and clinical data strongly suggests that nitric oxide (NO) plays a pivotal role in migraine. This is also supported by studies of migraine induced by substances that release NO. NO is synthesized from L-arginine by endothelial NO synthase (NOS). Asymmetric dimethylarginine (ADMA) is the major endogenous competitive inhibitor of NOS. Symmetric dimethylarginine (SDMA) is an inactive stereoisomer of ADMA. It may reduce NO production by competing with arginine for cellular uptake. The aim of this study was to measure the levels of ADMA, SDMA and L-arginine in migraine patients during the interictal period. One hundred migraine patients and 100 healthy volunteers were recruited. The patients were in the interictal period and classified into two groups as having migraine with aura and migraine without aura. Their serum ADMA, SDMA and L-arginine levels were measured by high-performance liquid chromotography (HPLC) method. ADMA, SDMA and L-arginine levels were significantly higher in migraine patients compared to the control group. But there was no difference between the patients with and without aura. These results suggest that NOS inhibitors and L-arginine/NO pathway plays an important role in migraine pathopysiology.
- 28 April 2017
- Published by Springer Nature in Neurological Sciences
- Vol. 38 (7) , 1287-1291
High asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in migraine patients
Experimental and clinical data strongly suggests that nitric oxide (NO) plays a pivotal role in migraine. This is also supported by studies of migraine induced by substances that release NO. NO is synthesized from L-arginine by endothelial NO synthase (NOS). Asymmetric dimethylarginine (ADMA) is the major endogenous competitive inhibitor of NOS. Symmetric dimethylarginine (SDMA) is an inactive stereoisomer of ADMA. It may reduce NO production by competing with arginine for cellular uptake. The aim of this study was to measure the levels of ADMA, SDMA and L-arginine in migraine patients during the interictal period. One hundred migraine patients and 100 healthy volunteers were recruited. The patients were in the interictal period and classified into two groups as having migraine with aura and migraine without aura. Their serum ADMA, SDMA and L-arginine levels were measured by high-performance liquid chromotography (HPLC) method. ADMA, SDMA and L-arginine levels were significantly higher in migraine patients compared to the control group. But there was no difference between the patients with and without aura. These results suggest that NOS inhibitors and L-arginine/NO pathway plays an important role in migraine pathopysiology.